Edition:
United States

Hubei Jumpcan Pharmaceutical Co Ltd (600566.SS)

600566.SS on Shanghai Stock Exchange

40.43CNY
17 Aug 2018
Change (% chg)

¥-1.02 (-2.46%)
Prev Close
¥41.45
Open
¥41.48
Day's High
¥41.85
Day's Low
¥40.15
Volume
3,819,911
Avg. Vol
4,708,984
52-wk High
¥54.97
52-wk Low
¥34.35

Latest Key Developments (Source: Significant Developments)

Hubei Jumpcan Pharmaceutical's H1 Net Profit Up 44.8 Percent Y/Y
Friday, 27 Jul 2018 07:20am EDT 

July 27 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>::SAYS H1 NET PROFIT UP 44.8 PERCENT Y/Y AT 842.5 MILLION YUAN ($123.37 million).  Full Article

Hubei Jumpcan Pharmaceutical to pay 2017 A shares dividend on June 1
Friday, 25 May 2018 04:34am EDT 

May 25(Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says it will pay a cash dividend of 10 yuan per 10 shares(before tax) for 2017, to shareholders of A shares recorded on May 31 .Says the company's shares will be traded ex-right and ex-dividend on June 1 and the dividend will be paid on June 1 .  Full Article

Hubei Jumpcan Pharmaceutical to lower conversion price of convertible corporate bonds to 40.04 yuan per share
Friday, 25 May 2018 04:32am EDT 

May 25(Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says it plans to lower conversion price of convertible corporate bonds to 40.04 yuan per share from 41.04 yuan per share, effective June 1.  Full Article

Hubei Jumpcan Pharmaceutical unit receives GMP certificate
Thursday, 11 Jan 2018 03:13am EST 

Jan 11 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Shaanxi Food and Drug Administration .Certificate issued to unit's products including troche, hard capsule and granula .Valid period is until Dec. 27, 2022.  Full Article

Hubei Jumpcan Pharmaceutical unit receives GMP certificate
Tuesday, 2 Jan 2018 04:43am EST 

Jan 2(Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says its wholly owned unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration.Says the valid period is until Dec. 25, 2022.  Full Article

Hubei Jumpcan Pharmaceutical's shareholder to cut stake in the company
Friday, 8 Dec 2017 05:47am EST 

Dec 8 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>::SAYS SHAREHOLDER PLANS TO UNLOAD ENTIRE HOLDINGS OF 2.65 PERCENT STAKE IN THE COMPANY WITHIN SIX MONTHS.  Full Article

Hubei Jumpcan Pharmaceutical issues 843.2 mln yuan convertible corporate bonds
Friday, 17 Nov 2017 04:26am EST 

Nov 17(Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says it issued 843.2 million yuan convertible corporate bonds.Previous news was disclosed on Nov. 8.  Full Article

Hubei Jumpcan Ppharmaceutical's 9-month net profit up 34.2 pct y/y
Monday, 16 Oct 2017 03:58am EDT 

Oct 16 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says 9-month net profit up 34.2 percent y/y at 907.3 million yuan ($137.77 million).  Full Article

Hubei Jumpcan Pharmaceutical cuts convertible bond issue size to up to 843.2 mln yuan
Monday, 31 Jul 2017 12:08am EDT 

July 30 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:* Says it cuts convertible bond issue size to up to 843.2 million yuan from up to 860 million yuan .  Full Article

Hubei Jumpcan Pharma's Q1 net profit up 39.0 pct y/y
Friday, 28 Apr 2017 08:57am EDT 

April 28 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says q1 net profit up 39.0 percent y/y at 290.7 million yuan ($42.17 million).  Full Article

BRIEF-Hubei Jumpcan Pharmaceutical unit obtains high-tech enterprise recognition and to enjoy tax preference

* Says its wholly owned subsidiary was recognized as high-tech enterprise again, and to enjoy a tax preference of 15 percent for three years from 2017 to 2019